192 related articles for article (PubMed ID: 144323)
1. Biologic actions of heparin.
Rosenberg RD
Semin Hematol; 1977 Oct; 14(4):427-40. PubMed ID: 144323
[No Abstract] [Full Text] [Related]
2. Chemistry of the hemostatic mechanism and its relationship to the action of heparin.
Rosenberg RD
Fed Proc; 1977 Jan; 36(1):10-8. PubMed ID: 63388
[No Abstract] [Full Text] [Related]
3. Heparin - plasmaprotein interactions. Current status.
Steinbuch M
Rev Fr Transfus Immunohematol; 1982 Apr; 25(2):217-38. PubMed ID: 7048490
[No Abstract] [Full Text] [Related]
4. Heparin, antithrombin, and abnormal clotting.
Rosenberg RD
Annu Rev Med; 1978; 29():367-78. PubMed ID: 77142
[No Abstract] [Full Text] [Related]
5. Actions and interactions of antithrombin and heparin.
Rosenberg RD
N Engl J Med; 1975 Jan; 292(3):146-51. PubMed ID: 127943
[No Abstract] [Full Text] [Related]
6. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
Kudrjashov BA; Pastorova VE; Lyapina LA
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
[TBL] [Abstract][Full Text] [Related]
7. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
Rosenberg RD
Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
[TBL] [Abstract][Full Text] [Related]
8. [Role of heparin in the process of blood coagulation and fibrinolysis].
Liapina LA
Usp Sovrem Biol; 1977; 84(3):338-52. PubMed ID: 343416
[No Abstract] [Full Text] [Related]
9. Activation of coagulation and platelets by candidate membranes of implantable devices in a whole blood model without soluble anticoagulant.
Sokolov A; Hellerud BC; Tønnessen TI; Johannessen EA; Mollnes TE
J Biomed Mater Res A; 2013 Feb; 101(2):575-81. PubMed ID: 22949225
[TBL] [Abstract][Full Text] [Related]
10. INTRAVASCULAR COAGULATION AND FIBRINOLYSIS BY STAPHYLOCOAGULASE. COMPARISON WITH THROMBIN.
JELJASZEWICZ J; NIEWIAROWSKI S; POPLAWSKI A; PROKOPOWICZ J; WOROWSKI K
Thromb Diath Haemorrh; 1965 Jun; 13():457-69. PubMed ID: 14347867
[No Abstract] [Full Text] [Related]
11. Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation.
Choi G; Vlaar AP; Schouten M; Van't Veer C; van der Poll T; Levi M; Schultz MJ
Eur Respir J; 2007 Sep; 30(3):423-8. PubMed ID: 17537762
[TBL] [Abstract][Full Text] [Related]
12. Blood coagulation and related plasma enzymes in inflammation.
Donaldson VH
Ser Haematol; 1970; 3(1):39-95. PubMed ID: 4943386
[No Abstract] [Full Text] [Related]
13. Modulation of blood coagulation and fibrinolysis by polyamines in the presence of glycosaminoglycans.
Homma R; Mase A; Toida T; Kashiwagi K; Igarashi K
Int J Biochem Cell Biol; 2005 Sep; 37(9):1911-20. PubMed ID: 15936241
[TBL] [Abstract][Full Text] [Related]
14. [Thrombin time and antithrombin power of human plasma in the presence of heparin and some synthetic heparinoids].
BURSTEIN M; GUINAND A
J Physiol (Paris); 1955; 47(1):115-7. PubMed ID: 13243272
[No Abstract] [Full Text] [Related]
15. Studies of biologic properties of a polysulfated chondroitin, A73025.
Radhakrishnamurthy B; Godofsky A; Dalferes ER; Srinivasan S; Vijayagopal P; Berenson G
Proc Soc Exp Biol Med; 1980 Sep; 164(4):410-4. PubMed ID: 7413661
[No Abstract] [Full Text] [Related]
16. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
Elgue G; Blombäck M; Olsson P; Riesenfeld J
Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of inhibition of blood coagulation (author's transl)].
Kurachi K
Tanpakushitsu Kakusan Koso; 1980 Dec; 25(13):1031-40. PubMed ID: 7025099
[No Abstract] [Full Text] [Related]
18. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?
Brinks HJ; Weerwind PW; Bogdan S; Verbruggen H; Brouwer MH
Perfusion; 2001 Jan; 16(1):3-12. PubMed ID: 11192305
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
Meddahi S; Bara L; Fessi H; Samama MM
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of the anticoagulant effects of glycosaminoglycans by serum amyloid P component: comparison with other plasma and platelet proteins.
Williams EC; Huppert BJ; Asakura S
J Lab Clin Med; 1992 Jul; 120(1):159-67. PubMed ID: 1377216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
